Adastra Pharmaceuticals

Adastra Pharmaceuticals (previously known as Tragara Pharmaceuticals) is an oncology company. It develops Zotiraciclib, a clinical candidate for the treatment of brain cancers, such as glioblastoma and hepatocellular carcinoma.